FEB 14, 2019 1:30 PM PST

Organs On a Chip: A Revolution in Drug Development?

C.E. Credits: RACE
  • Scientific Director, Analytical Development, Small Molecule Pharmaceutical Development, The Janssen Pharmaceutical Companies of Johnson & Johnson
      Dr. Yoder received his PhD in analytical chemistry from the University of Illinois at Chicago. He has over 15 years of industrial experience in analytical development and characterization supporting API and formulation development. He has solid experience in oral (solid and liquid), parenteral, inhalation dosage forms (MDI, DPI, and nebulized products), and large molecule therapeutics. He also has broad experience in characterization of small molecules and bio-macromolecules and he has exploited several analytical tools to support API and formulation development initiatives.


    Pharmaceutical research and development efforts are often both inefficient and suffer from a high attrition rate of drug candidates within the clinical phase of development.  Most drug trials either fail to meet their expected endpoints or show minimal statistical differentiation between active and placebo (i.e. efficaciousness).  In other instances, failures might occur due to safety reasons.  Clearly, a fundamental understanding of drug properties in the discovery and early phases of development as well as an accrual of knowledge regarding mechanisms of disease and clinical trial learnings is essential to increase productivity and success for ongoing drug development efforts.

    Assuming that much of prior knowledge from prior drug development and trial efforts could be aggregated within some form of data management system, it has been proposed that systematic modeling and simulation-based trial designs could enhance the odds for successful commercialization of new drug entities.  To that end, the application of micro-physiological systems (MPS) or organs-on-a-chip in drug discovery for the development of enhanced in-vitro models to simulate or predict in-vivo processes has begun to show a lot of potential.  

    While the utilization of MPS-based technologies could someday reap enormous scientific and regulatory benefits for patients, certain barriers must still be overcome which are impactful to the evolution and future implementation of these technologies.  The intrinsic challenges as well as potential solutions will be discussed.

    Learning Objectives: 

    1. Learn about intrinsic challenges and potential solutions
    2. Immediate outcomes of utilizing reliable in-vitro models

    Show Resources
    You May Also Like
    AUG 25, 2020 8:00 AM PDT
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    NOV 16, 2020 8:00 AM PST
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    SEP 10, 2020 9:00 AM PDT
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 16, 2020 8:00 AM PST
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    DEC 02, 2020 8:00 AM PST
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    FEB 14, 2019 1:30 PM PST

    Organs On a Chip: A Revolution in Drug Development?

    C.E. Credits: RACE


    Animal Research

    Animal Models

    Life Science

    Animal Sciences






    Cell Biology

    Molecular Biology

    Veterinary Sciences


    Animal Behavior

    Research And Development



    North America8%


    South America1%

    Registration Source

    Website Visitors99%

    Job Title


    Post Doc15%

    Research Scientist13%

    Medical Laboratory Technician11%



    Medical Doctor/Specialist6%

    Facility/Department Manager3%

    Clinical Laboratory Scientist3%


    Lab Management2%

    Veterinary Technician2%

    Animal Care Lab Technician2%




    Academic Institution56%


    Research Institute8%

    Industrial Company3%

    Medical Center2%

    Clinical Laboratory2%

    Pharmaceutical Company2%

    Ambulatory Care1%

    Medical School1%

    Manufacturer & Biotech/pharma1%

    Contract Research Organization (Cro)1%


    Independent Laboratories1%


    Show Resources
    Loading Comments...
    Show Resources
    • See more